Ricken Benjamin, Fellmann Oliver, Kohler Hans-Peter E, Schäffer Andreas, Corvini Philippe François-Xavier, Kolvenbach Boris Alexander
Institute for Ecopreneurship, School of Life Sciences, University of Applied Sciences and Arts Northwestern Switzerland, Gruendenstrasse 40, 4132 Muttenz, Switzerland.
Swiss Federal Institute of Aquatic Science and Technology, Department of Environmental Microbiology, Eawag, Überlandstrasse 133, 8600 Dübendorf, Switzerland.
N Biotechnol. 2015 Dec 25;32(6):710-5. doi: 10.1016/j.nbt.2015.03.005. Epub 2015 Mar 18.
Microbacterium sp. strain BR1 is among the first bacterial isolates which were proven to degrade sulfonamide antibiotics. The degradation is initiated by an ipso-substitution, initiating the decay of the molecule into sulfur dioxide, the substrate specific heterocyclic moiety as a stable metabolite and benzoquinone imine. The latter appears to be instantaneously reduced to p-aminophenol, as that in turn was detected as the first stable intermediate. This study investigated the downstream pathway of sulfonamide antibiotics by testing the strain's ability to degrade suspected intermediates of this pathway. While p-aminophenol was degraded, degradation products could not be identified. Benzoquinone was shown to be degraded to hydroquinone and hydroquinone in turn was shown to be degraded to 1,2,4-trihydroxybenzene. The latter is assumed to be the potential substrate for aromatic ring cleavage. However, no products from the degradation of 1,2,4-trihydroxybenzene could be identified. There are no signs of accumulation of intermediates causing oxidative stress, which makes Microbacterium sp. strain BR1 an interesting candidate for industrial waste water treatment.
微杆菌属菌株BR1是首批被证明能降解磺胺类抗生素的细菌分离株之一。降解过程由亲核取代引发,使分子分解为二氧化硫、作为稳定代谢物的底物特异性杂环部分和苯醌亚胺。后者似乎会立即还原为对氨基苯酚,而对氨基苯酚又被检测为首个稳定中间体。本研究通过测试该菌株降解此途径可疑中间体的能力,对磺胺类抗生素的下游途径进行了研究。虽然对氨基苯酚被降解,但无法鉴定出降解产物。苯醌被证明可降解为对苯二酚,而对苯二酚又被证明可降解为1,2,4-三羟基苯。后者被认为是芳香环裂解的潜在底物。然而,无法鉴定出1,2,4-三羟基苯降解的产物。没有迹象表明中间体会积累从而导致氧化应激,这使得微杆菌属菌株BR1成为工业废水处理的一个有趣候选菌株。